Simcere Pharmaceutical Group (NYSE:SCR) a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, recently reported unaudited financial results for the quarter ended September 30, 2010.